The Hydroxamic Acids as a Potential Anticancer and Neuroprotective Agents

(E-pub Ahead of Print)

Author(s): Margarita E. Neganova, Sergey G. Klochkov, Yulia R. Aleksandrova, Gjumrakch Aliev*

Journal Name: Current Medicinal Chemistry

Become EABM
Become Reviewer
Call for Editor


Hydroxamic acids are a promising class of chemical compounds with proven antitumor potential, primarily due to its ability to inhibit the activity of histone deacetylase enzymes. The analysis of modern experimental data shows a wide range of biological activity for hydroxamic acids, which makes them equally worthy candidates for the fight against neuropathologies. A characteristic feature of hydroxamic acids is their ability to act simultaneously on several promising molecular targets for the correction of both neuropathologies and oncological diseases, thereby exhibiting multifunctionality. This review discusses the effect of hydroxamic acids on key parts of cancer and neurodegenerative disorders pathogenesis. Pathological changes in the processes associated with oxidative stress, the functioning of mitochondria, and the activity of metal enzymes of the class of histone deacetylases, as the main links in the epigenetic regulation of pathological conditions, are such molecular targets.

Keywords: Hydroxamic acids, cancer, neurodegenerative diseases, oxidative stress, mitochondria, histone deacetylase.

Rights & PermissionsPrintExport Cite as

Article Details

Published on: 18 December, 2020
(E-pub Ahead of Print)
DOI: 10.2174/0929867328666201218123154
Price: $95

Article Metrics

PDF: 273